Suchergebnisse - "Chartier, Florence"

PubPharm (20)

1

Generalizability of clinical trial efficacy results to a real-world population : An example in migraine prevention

enthalten in: Journal of managed care & specialty pharmacy | 2023

von Paget, M. | Tockhorn-Heidenreich, A. | Belger, M. | +2

2

Cardiovascular Profile of Patients with Type 2 Diabetes in France Based on REWIND CVOT Inclusion Criteria : A Real-World Retrospective Study

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2022

von Dib, A. | Chartier, F. | Ihle, K. | +3

3

Conversations and reactions around severe hypoglycemia (CRASH) global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers : Findings from the French cohort

enthalten in: Annales d'endocrinologie | 2022

von Chevalier, N. | Penfornis, A. | Riveline, J. | +7

4

Cardiovascular Profile of Patients with Type 2 Diabetes in France Based on REWIND CVOT Inclusion Criteria: A Real-World Retrospective Study

enthalten in: Diabetes therapy | 2022

von Dib, A. | Chartier, F. | Ihle, K. | +3

5

Cardiovascular Profile of Patients with Type 2 Diabetes in France Based on REWIND CVOT Inclusion Criteria: A Real-World Retrospective Study

enthalten in: Diabetes therapy | 2022

von Dib, A. | Chartier, F. | Ihle, K. | +3

6

Cardiovascular Profile of Patients with Type 2 Diabetes in France Based on REWIND CVOT Inclusion Criteria: A Real-World Retrospective Study

enthalten in: Diabetes therapy | 2022

von Dib, A. | Chartier, F. | Ihle, K. | +3

7

Resource Use and Cost of Alzheimer's Disease in France : 18-Month Results from the GERAS Observational Study

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2018

von Rapp, T. | Andrieu, S. | Chartier, F. | +4

8

The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2018

von Basson, M. | Ntais, D. | Ayyub, R. | +5

9

The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France

enthalten in: Diabetes therapy | 2017

von Basson, M. | Ntais, D. | Ayyub, R. | +5

10

The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France

enthalten in: Diabetes therapy | 2017

von Basson, M. | Ntais, D. | Ayyub, R. | +5